Using microscale channels cut in an ultrathin biodegradable polymer, a researcher at the U.S. Department of Energy’s Ames Laboratory is working to regrow nerve cells. The technique, which may one day allow the paralyzed to walk and the blind to see, has been proven to work for peripheral nerve regeneration in laboratory rats.
While type 1 Neurofibromatosis (NF1) is primarily known to cause tumors of the nervous system, scientists were puzzled as to why patients with NF1 are also prone to cardiovascular problems such as hypertension and congenital heart disease. Researchers from the University of Pennsylvania School of Medicine have solved this particular part of the puzzle by showing how the Nf1 gene – which is mutated in those suffering from Neurofibromatosis – is also essential in endothelial cells, the cells that make up blood vessels.